Article

Discovering potent inhibitors against the Mpro of the SARS-CoV-2. A Medicinal Chemistry approach.

2021-07-29

Abstract excerpt

The global pandemic caused by a single-stranded RNA (ssRNA) virus known as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still at its peak, with new cases being reported daily. Though the vaccinations are done on a massive scale, the frequent mutations in the viral gene and resilience of the future strains could be more problematic. Therefore, there is always a need for new compounds to be av...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4a9f0f3a-dc6c-57da-8fe8-4b2a41c73869
DOI: 10.22541/au.162751885.54678505/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Discovering potent inhibitors against the Mpro of the SARS-CoV-2. A Medicinal Chemistry approach.DOI 10.22541/au.162751885.54678505/v1Read

Structure-Based Virtual Screening to Discover Potential Lead Molecules for the SARS-CoV‑2 Main ProteaseSemantic proximity Read

In-Silico Lead Druggable Compounds Identification against SARS COVID-19 Main Protease Target from In-House, Chembridge and Zinc Databases by Structure-Based Virtual Screening, Molecular Docking and Molecular Dynamics SimulationsSemantic proximity Read

Identification of Potential Antiviral Lead Inhibitors Against Sars-Cov-2 Main Protease: Structure-Guided Virtual Screening, Docking, Adme, and Md Simulation Based ApproachSemantic proximity Read

Massive Virtual screening and evaluation of small molecule inhibitors of the Papain-like protease of SARS-CoV-2Semantic proximity Read

Identification of promising high-affinity inhibitors of SARS-CoV-2 main protease from African Natural Products Databases by Virtual ScreeningSemantic proximity Read

Pharmacophore Analyses of SARS-CoV-2 Active Main Protease Inhibitors Using Pharmacophore Query and Docking StudySemantic proximity Read

Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel In Silico MethodSemantic proximity Read

Nature Potential for COVID-19: Targeting SARS-CoV-2 Mpro Inhibitor with Bioactive CompoundSemantic proximity Read

Is PF-00835231 a Pan-SARS-CoV-2 Mpro Inhibitor? A Comparative StudySemantic proximity Read

In Silico Elucidation of Potent Inhibitors and Rational Drug Design against SARS-CoV-2 Papain-like ProteaseSemantic proximity Read

Old Arsenal to Combat New Enemy: Repurposing of Commercially Available FDA Approved Drugs Against Main Protease of SARS-CoV2.Semantic proximity Read

Massive Virtual screening and evaluation of small molecule inhibitors of the Papain-like protease of SARS-CoV-2Semantic proximity Read